ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 28 filers reported holding ANNOVIS BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,388 | -62.2% | 1,200 | -44.3% | 0.00% | – |
| Q2 2023 | $30,130 | -1.1% | 2,156 | 0.0% | 0.00% | – |
| Q1 2023 | $30,461 | -32.3% | 2,156 | -35.9% | 0.00% | – |
| Q4 2022 | $45,000 | 0.0% | 3,366 | +2.6% | 0.00% | – |
| Q3 2022 | $45,000 | +80.0% | 3,280 | +58.5% | 0.00% | – |
| Q2 2022 | $25,000 | -34.2% | 2,070 | -27.9% | 0.00% | – |
| Q1 2022 | $38,000 | -75.0% | 2,870 | -66.6% | 0.00% | – |
| Q4 2021 | $152,000 | -56.4% | 8,594 | -21.9% | 0.00% | -100.0% |
| Q3 2021 | $349,000 | +134.2% | 11,002 | +531.6% | 0.00% | – |
| Q2 2021 | $149,000 | +27.4% | 1,742 | -58.5% | 0.00% | – |
| Q1 2021 | $117,000 | +108.9% | 4,200 | -43.2% | 0.00% | – |
| Q4 2020 | $56,000 | +47.4% | 7,396 | -5.6% | 0.00% | – |
| Q3 2020 | $38,000 | +1800.0% | 7,834 | +1743.3% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 425 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 48,941 | $464,450 | 0.22% |
| Redmond Asset Management, LLC | 34,080 | $323,419 | 0.12% |
| Sterling Investment Advisors, Ltd. | 34,374 | $326,209 | 0.11% |
| Wescott Financial Advisory Group, LLC | 41,607 | $394,850 | 0.07% |
| Worth Venture Partners, LLC | 12,321 | $116,926 | 0.07% |
| Koshinski Asset Management, Inc. | 15,000 | $142,350 | 0.02% |
| Merit Financial Group, LLC | 41,200 | $390,988 | 0.01% |
| FNY Investment Advisers, LLC | 1,133 | $10 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | $2,847,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 23,600 | $223,964 | 0.01% |